IAP & JPS 2022IAP & JPS 2022


Call For Abstracts

We added more symposium!

Presentation Style*

Abstracts can be accepted as Oral Session, Mini-Oral Session, or Main Session. We look forward to your submissions.

If you are an invited speaker, please choose the “Invited Speaker” on the Submission Website. Please read the instruction carefully and submit your abstract through the Submission Website below.

Acceptance, Presentation Style, Date and Time, etc. will be selected by the President.

1. Submission Period

Noon on December 1 (Wed), 2021 -  Noon on February 4 (Fri), 2022 (Japan Time)
Noon on February 14 (Mon), 2022 (Japan Time)
Noon on February 20 (Sun), 2022 (Japan Standard Time)

Abstract Submission has been closed.

Attention !
Submission Website is available after the deadline for Invited Speakers. However, if you are not Invited Speakers, your abstracts will NOT be registered or modified after the deadline.

There will be a heavy access at the last minutes.
We recommend you make preparations in good time.
Before the deadline, you can modify your abstracts.

2. Eligibility

The submitted abstract must describe unpublished work.
We evaluate research content, ethics, etc. before determining if your abstract will be accepted. Accepted abstract will be Oral Presentation or Mini Oral Presentation. The President will determine if it is accepted or not.

3. Language / Number or Characters, etc.

Presentation and Presentation Slide has to be English.

  • Abstract Title: 100 characters (including spaces)
  • Abstract Body: 1,650 characters (roughly 300 words) (including spaces)
  • Authors (1st authors and co-authors): limited to 20
  • Affiliations: limited to 10
  • Total number of characters (Authors, Affiliations, Abstract Title, and Abstract Body): 2000 characters (including spaces)

After the deadline, no change will be acceptable.

4. Session Category

1Please select one of the Session below.

  • Oral Session
  • Main Session
  • Invited Session

2If you select Oral or Main Session, please choose Category below.

  1. Pancreatic Exocrine
  2. Pancreatic Endocrine
  3. Acute Pancreatitis
  4. Chronic Pancreatitis
  5. Autoimmune Pancreatitis
  6. Pancreatic Cancer
  7. Pancreatic Endocrine Tumor
  8. Cystic Pancreas Tumor
  9. Other Pancreas Tumor
  10. Pancreatic Transplantation
  11. Medical Staff
  12. Others
2nd Category
  1. Basic
  2. Diagnosis
  3. Treatment
  4. Case Study
  5. Others

3If you apply for Oral Session, please select Oral or Mini Oral.

4If you apply for Main Session, please select one of the sessions below. In case your abstract will not be accepted for the Main Session, please select if you apply for the Oral Session or not.


Advances in genomics for pancreatic neoplasms
Progress of basic researches in chronic pancreatitis
International symposium on endotherapy for chronic pancreatitis
Multidisciplinary treatment for PanNEN with distant metastases
Progress of basic researches on the link between pancreatogenesis and cancer
(in collaboration with the 7th JCA-AACR Special Joint Conference in Kyoto)
Neoadjuvant therapy for resectable and bordeline-resectable pancreatic cancer
Novel techniques to prevent pancreatic fistula in distal pancreatectomy
Interventional endoscopy for pancreatic cancer

Additional Symposium

Progress in the management of acute pancreatitis
Updates on familial pancreatic cancer
Molecular profiling of pancreatic cancer and application of liquid biopsy to clinical practice
Palliative therapy for pancreatic cancer
New modalities for the management of PanNEN
Challenges to acurate disgnosis and optimal treatment of pancreatic cystic neoplasms
Nutrition management for patients with pancreatic diseases

Video Symposium

Minimaly invasive distal pancreatectomy for pancreatic cancer
Significance of vascular resection for advanced pancreatic cancer

Panel Discussion

Updates on autoimmune pancreatitis
Reappraisal of total pancreatectomy: Indications, outcomes, perioperative management.
Quest for early diagnosis of pancreatic cancer
Total neoadjuvant therapy for pancreatic cancer


Basic & translational researches on PanNEN: bench to bedside

Internal Consensus Meeting

Revision of international consensus on borderline-resectable pancreatic cancer

Debate Session

Minimally invasive pancreatic surgery: Laparoscopic vs Robotic

5. Disclosure of Conflicts of Interest (COI)

Every speaker needs to disclose his/her Conflicts of Interest.

On the second slide of your presentation, you need to add a COI slide.
(Even when you do not have any conflicts.)

If the lead presenter is the responsible researcher, choose the sample slide 1.
If the lead presenter is NOT the responsible researcher, choose the sample slide 2 and prepare each COI disclosure slide on behalf of the responsible researcher.

1) Lead presenter is the responsible researcher
COI Sample 1

2) Lead presenter is NOT the responsible researcher
COI Sample 2

6. Notification

Program will be determined by the President.
Notification will be sent to the 1st author’s email around March in 2022.

Attention !
If you register Webmail (ex: Gmail, Yahoo mail) as your email, sometimes you can not receive our email. We recommend you not to use the Webmail.

8. Contact

IAP & JPS 2022
Management Office
c/o Japan Convention Services, Inc.
Email: program-53jps@convention.co.jp

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about Cookie policy.
You can change your cookie settings at any time.